First Episealer® surgery in Portugal scheduled
Episurf Medical (Nasdaq: EPIS B) today announces that the first Episealer® surgery (Episealer® Knee) in Portugal has been scheduled. The Episealer® Knee and Episealer® Talus implants were recently registered and approved for sale and distribution in Portugal. “We are adding yet another country in which the Episealer® implants are used, and I am pleased that our global regulatory strategy results in additional surgeries in more and more countries,” says Pål Ryfors, CEO Episurf Medical.